A promising new vaccine under development at Massachusetts General Hospital is raising hope in the urgent search for protection against COVID-19.
A concept known as “prehabilitation” is boosting fitness and overall health for patients preparing for cancer surgery and other demanding treatments.
A consortium of scientists, co-led by Mass General’s Bruce Walker, MD, is working to uncover the biological secrets of the coronavirus.
The unrestricted funding of the MGH Research Scholars program empowers scientists to meet the challenges of the COVID-19 pandemic.
Mass General clinicians who treat substance use disorders are putting new regulatory changes into action for their patients during the pandemic.
Addressing one of the greatest challenges of modern cancer treatment, Russell Jenkins, MD, PhD, is working to predict who will respond to immunotherapy treatment.
Using single-celled yeast, a trailblazing researcher at the Mass General Cancer Center has developed a way to lure dormant cancer cells out of hiding so cancer therapy can do its work.
Lily Haseotes Bentas and her husband, Efthemios J. Bentas, are creating a lasting endowment for cancer research with a focus on women scientists.
In labs across Mass General, researchers are guiding patient blood samples through the tiny channels of an innovative device that could open doors to faster, easier cancer detection.
Raina McMahan leads a team of Mass General recovery coaches who tap their personal experience with substance use disorder to guide others toward recovery.